Peer review reports
From: Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy
Original Submission |
30 Aug 2022 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
2 Oct 2022 |
Reviewed |
Reviewer Report
|
20 Oct 2022 |
Reviewed |
Reviewer Report
|
31 Oct 2022 |
Reviewed |
Reviewer Report
|
1 Dec 2022 |
Author responded |
Author comments - Julien Taieb
|
Resubmission - Version 5 |
1 Dec 2022 |
Submitted |
Manuscript version 5
|
13 Dec 2022 |
Author responded |
Author comments - Julien Taieb
|
Resubmission - Version 6 |
13 Dec 2022 |
Submitted |
Manuscript version 6
|
19 Dec 2022 |
Reviewed |
Reviewer Report
|
Resubmission - Version 7 |
|
Submitted |
Manuscript version 7
|
Publishing |
26 Dec 2022 |
Editorially accepted |
|
27 Jan 2023 |
Article published |
10.1186/s12885-022-10489-4
|
Learn about peer review